UPDATE 2-S.Korea's Celltrion aims to start in-human COVID-19 drug trial in July
June 01, 2020 at 01:44 AM EDT
South Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated an up to 100-fold reduction in viral load of the disease in animal testing, saying it aims to start in-human clinical trials in late July.
